77 related articles for article (PubMed ID: 38166957)
1. Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases.
Huang S; Liu Y; Yan W; Zhang T; Wang P; Zhu M; Zhang X; Zhou P; Fan Z; Yu H
Pediatr Rheumatol Online J; 2024 May; 22(1):58. PubMed ID: 38783316
[TBL] [Abstract][Full Text] [Related]
2. Treatment of systemic juvenile idiopathic arthritis.
Hinze CH; Foell D; Kessel C
Nat Rev Rheumatol; 2023 Dec; 19(12):778-789. PubMed ID: 37923864
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of emapalumab in macrophage activation syndrome.
De Benedetti F; Grom AA; Brogan PA; Bracaglia C; Pardeo M; Marucci G; Eleftheriou D; Papadopoulou C; Schulert GS; Quartier P; Antón J; Laveille C; Frederiksen R; Asnaghi V; Ballabio M; Jacqmin P; de Min C
Ann Rheum Dis; 2023 Jun; 82(6):857-865. PubMed ID: 37001971
[TBL] [Abstract][Full Text] [Related]
4. Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease.
Huang Y; Sompii-Montgomery L; Patti J; Pickering A; Yasin S; Do T; Baker E; Gao D; Abdul-Aziz R; Behrens EM; Canna S; Clark M; Co DO; Collins KP; Eberhard B; Friedman M; Graham TB; Hahn T; Hersh AO; Hobday P; Holland MJ; Huggins J; Lu PY; Mannion ML; Manos CK; Neely J; Onel K; Orandi AB; Ramirez A; Reinhardt A; Riskalla M; Santiago L; Stoll ML; Ting T; Grom AA; Towe C; Schulert GS
Arthritis Care Res (Hoboken); 2024 Mar; 76(3):328-339. PubMed ID: 37691306
[TBL] [Abstract][Full Text] [Related]
5. Macrophage activation syndrome in a patient with systemic onset of the juvenile idiopathic arthritis.
Jain D; Aggarwal HK; Rao A; Mittal A; Jain P
Reumatologia; 2016; 54(1):42-7. PubMed ID: 27407277
[TBL] [Abstract][Full Text] [Related]
6. A MASsive attack: a pediatric case of macrophage activation syndrome complicated by DIC as an onset of systemic juvenile idiopathic arthritis successfully treated with anakinra and review of the literature.
Maeser A; Biernacka-Zielinska M; Smolewska E
Rheumatol Int; 2024 Mar; ():. PubMed ID: 38502236
[TBL] [Abstract][Full Text] [Related]
7. Predictors of disease course in systemic juvenile idiopathic arthritis.
Kaplan MM; Tekin ZE; Çelikel E; Güngörer V; Karagöl C; Öner N; Polat MC; Öztürk D; Özçelik E; Ekici MI; Acar BÇ
Mod Rheumatol; 2024 Apr; ():. PubMed ID: 38590038
[TBL] [Abstract][Full Text] [Related]
8. Macrophage activation syndrome in a Sudanese child: a case report from Sudan.
Yahia Elhassan MA; Hussain Idres RM; Mohamed Elhassan BMS; Banaga Siddiq NS; Osman Mohammed RA; Mahmmoud Fadelallah Eljack M; Mustafa GE; Hemmeda L; Abbasher Hussien Mohamed Ahmed K
Ann Med Surg (Lond); 2024 May; 86(5):3047-3051. PubMed ID: 38694344
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
Avau A; Matthys P
Pharmaceuticals (Basel); 2015 Nov; 8(4):793-815. PubMed ID: 26610523
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy: more difficult to diagnose, not to control?
Quartier P
Rheumatology (Oxford); 2024 May; ():. PubMed ID: 38733595
[No Abstract] [Full Text] [Related]
11. Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Boom V; Anton J; Lahdenne P; Quartier P; Ravelli A; Wulffraat NM; Vastert SJ
Pediatr Rheumatol Online J; 2015 Dec; 13():55. PubMed ID: 26634252
[TBL] [Abstract][Full Text] [Related]
12. Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome.
Wagner-Weiner L
Pediatr Ann; 2015 Jun; 44(6):e142-7. PubMed ID: 26114369
[TBL] [Abstract][Full Text] [Related]
13. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study.
Otar Yener G; Paç Kısaarslan A; Ulu K; Atalay E; Haşlak F; Özdel S; Bozkaya Yücel B; Gezgin Yıldırım D; Çakmak F; Öztürk K; Çakan M; Balık Z; Hasbal Akkuş C; Yıldız M; Erat T; Çetin BŞ; Yılmaz M; Bağlan E; Laçinel Gürlevik S; Atasayan V; Karadağ ŞG; Adrovic A; Çağlayan Ş; Tanatar A; Demirkan FG; Coşkuner T; Akgün Ö; Kasap Cüceoğlu M; Kavrul Kayaalp G; Şahin S; Başaran Ö; Demir F; Barut K; Çiftel M; Gürses D; Baykan A; Özsürekçi Y; Karagöz T; Sönmez HE; Bilginer Y; Aktay Ayaz N; Aydoğ Ö; Yüksel S; Sözeri B; Kasapçopur Ö; Özen S
Rheumatol Int; 2022 May; 42(5):879-889. PubMed ID: 34491393
[TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP
World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427
[TBL] [Abstract][Full Text] [Related]
15. A rare case of coronary artery complication in a child with systemic juvenile idiopathic arthritis and macrophage activation syndrome: case report and literature review.
Zhang L; Wei Y; Zeng N; Wang L; Chen X; Yang J; Xiao X
Pediatr Rheumatol Online J; 2024 Jan; 22(1):4. PubMed ID: 38166957
[TBL] [Abstract][Full Text] [Related]
16. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
